Restless legs syndrome/Willis‐Ekbom disease in type 2 diabetes as the initial manifestation of Parkinson's disease and major cardiovascular disease

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Psychogeriatrics 2017-11, Vol.17 (6), p.498-499
Hauptverfasser:	Hsu, Chun‐Hsien, Yu, Shu‐Man, Lau, Shu Chuen, Chen, Yen‐Lin, Pei, Dee, Liu, I‐Chao
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Amines - therapeutic use Analgesics - therapeutic use Anticonvulsants - therapeutic use Antihypertensive Agents - therapeutic use Antiparkinson Agents - therapeutic use Aspirin - therapeutic use Biphenyl Compounds - therapeutic use cardiovascular disease Carotid Stenosis - diagnosis Carotid Stenosis - drug therapy Clonazepam - therapeutic use Coronary Artery Disease - diagnosis Coronary Artery Disease - drug therapy Cyclohexanecarboxylic Acids - therapeutic use Diabetes mellitus Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - diagnosis gamma-Aminobutyric Acid - therapeutic use Humans Hypertension - diagnosis Hypertension - drug therapy Male Movement disorders Neurodegenerative diseases Parkinson Disease - diagnosis Parkinson Disease - drug therapy Parkinson's disease Quality of Life Restless legs syndrome Restless Legs Syndrome - diagnosis Restless Legs Syndrome - drug therapy restless legs syndrome/Willis‐Ekbom disease Sleep - physiology Tetrazoles - therapeutic use Treatment Outcome type 2 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!